SOURCE: PharmStar Pharmaceuticals, Inc.

April 11, 2011 15:36 ET

PharmStar Pharmaceuticals CEO to Appear on the Bill Chippas Show

Listen Live on Tuesday, April 12th at 10:20 am EDT

ROCKY MOUNT, NC--(Marketwire - Apr 11, 2011) - PharmStar Pharmaceuticals, Inc. (PINKSHEETS: PHAR), a U.S. drug developer, manufacturer and marketer of the FDA-approved, Over-the-Counter (OTC) liquid pain reliever Aquaprin™, announced today that its Chief Executive Officer, Howard Phykitt, will be interviewed on the Bill Chippas Show on Tuesday, April 12, 2011, which airs between 10:00 am to 11:00 am Eastern Time. Those interested in PharmStar Pharmaceuticals are encouraged to listen live tomorrow at 10:20 am ET by visiting www.billchippasshow.com or www.Princetonresearch.com.

Mr. Phykitt is the inventor Aquaprin, the signature pain reliever that is being commercialized for distribution by PharmStar. He will give insight into the development of Aquaprin and take questions from callers during his segment on the show. Callers can talk with Mr. Phykitt by calling 1-772-220-9788 or email questions during the show to Bill@Billchippasshow.com.

Since 2005, Bill has hosted the Bill Chippas Show in South Florida on AM 1590 and AM 1450. Individual investors, active traders and institutional professionals rely on Bill's timely unbiased analysis, deep rooted market background and experience spanning four decades to make intelligent and common sense investments. Bill's weekly Stock Market Comments appear in Weekly Market Strategies delivered by Princeton Research (www.princetonresearch.com) to global investors, and Bill's opinion columns appear in YourNews.com. In 1996, Bill founded FuturesCom, which remains one of today's longest running Internet-based, independent publications for investment market research. To learn more about Bill, visit www.billchippasshow.com.

About PharmStar Pharmaceuticals
PharmStar Pharmaceuticals, Inc. is a U.S.-based drug development, manufacturing and marketing company and the innovator of Aquaprin™, an FDA-approved Over-the-Counter (OTC) liquid pain reliever. In development since 1993 with over $3 million invested to-date, Aquaprin™ is a liquid derivative of aspirin based on a patent-pending formula. The product is designed to dissolve nearly instantly in just 1.5 ounces of water, which can be absorbed into the bloodstream up to 10 times faster than traditional OTC pain relievers, and with little to no stomach upset. PharmStar's headquarters are located in Rocky Mount, NC. For more information, visit www.pharmstarinc.com.

Forward-Looking Statements Disclosure
This press release includes "forward-looking statements" within the meaning of the federal securities laws, commonly identified by such terms as "believes," "will," "looking ahead," "anticipates," "estimates" and other terms with similar meaning. Although the Company believes that the assumptions upon which its forward-looking statements are based are reasonable, it can give no assurance that these assumptions will prove to be correct. Important factors that could cause actual results to differ materially from the Company's projections and expectations are disclosed in the Company's filings with the Securities and Exchange Commission. All forward-looking statements in this press release are expressly qualified by such cautionary statements and by reference to the underlying assumptions.

Contact Information